We then performed hierarchical clustering of tumor cell immunohistochemical (IHC) expression scores and correlated these findings with multiple characteristics of the tumor including sex, extent of disease, origin, anatomic site, prior treatment, CK7/CK20 status, vital status, and CD8 density within a series of predominantly in situ and invasive EMPD. This evidence concerns the gene KRT20 and neoplasm.